v3.19.3
Stockholders' Deficit (Details 2) - USD ($)
9 Months Ended
Sep. 30, 2019
Jun. 30, 2019
Aggregate Principal and Interest Consideration Exchanged/Paid   $ 182,523
Series RX-3 Preferred Stock [Member]    
Aggregate Principal and Interest Consideration Exchanged/Paid $ 481,212 $ 1,397,644
Total Number of RX- 3 Shares For Which Warrants Issued Are Exercisable   481,212
Series RX-3 Preferred Stock [Member] | Controller [Member]    
Aggregate Principal and Interest Consideration Exchanged/Paid $ 235,775  
Total Number of RX- 3 Shares For Which Warrants Issued Are Exercisable 81,806  
Total Number of Common Shares Into Which Shares are Convertible (Before Any Potential Adjustment) 81,806,000  
Series RX-3 Preferred Stock [Member] | President and chief executive officer [Member]    
Aggregate Principal and Interest Consideration Exchanged/Paid $ 609,716  
Total Number of RX- 3 Shares For Which Warrants Issued Are Exercisable 211,733  
Total Number of Common Shares Into Which Shares are Convertible (Before Any Potential Adjustment) 211,733,000  
Series RX-3 Preferred Stock [Member] | General Counsel [Member]    
Aggregate Principal and Interest Consideration Exchanged/Paid $ 552,156  
Total Number of RX- 3 Shares For Which Warrants Issued Are Exercisable 187,673  
Total Number of Common Shares Into Which Shares are Convertible (Before Any Potential Adjustment) 187,673,000  
Series RX-3 Preferred Stock [Member] | Preferred Stock Warrant One [Member]    
Aggregate Principal and Interest Consideration Exchanged/Paid   $ 1,397,647
Total Number of RX- 3 Shares For Which Warrants Issued Are Exercisable   481,212
Total Number of Common Shares Into Which Shares are Convertible (Before Any Potential Adjustment) 481,212,000